29 Oct 12
The global biopharmaceutical Industry has come a long way since its first drug - Humulin was approved in 1982. Today more than three hundred biopharmaceuticals have already been approved and many more are in late stages of clinical development. These drugs have not only advanced the prevention and treatment of a number of life threatening diseases, but have also provided the thrust for the continued success of the pharmaceutical industry.
18 Oct 12
PharmiWeb Solutions’ second Digital Breakfast opens new opportunities for Harnessing Big Data in Pharma
11 Oct 12
Next time you pop a pill from a packet, spare a thought about how it got to you.
Mikko Soirola, vice president Liaison Technologies
01 Oct 12
Despite many pledges from Government to change the employment law landscape, this October’s legislative programme is a relatively quiet one for employment lawyers and employers.
21 Sep 12
Across the healthcare and pharmaceutical sectors, nothing is simultaneously as important for patient safety and operational efficiency as the supply chain.
Roger Lamb, Healthcare Sector Manager, GS1 UK
13 Sep 12
The ability to sell yourself, develop new skills and offer relevant experience are just some of the ways you can stand out in today’s jobs market, according to recruiting experts Hays.
Kathy Lou, Marketing Manager of Hays in China.
12 Sep 12
There’s nothing like a tough market to force companies to take stock of their core business and reassess the best use of internal resources. Martin Magazzolo, global practice director of CSC Life Sciences’ Software Solutions Group, charts the move toward content as a service amid changing market dynamics.
12 Sep 12
2013 is tipped to be a milestone year for the global pharmaceutical industry. As a number of key blockbuster drugs face the expiry of their US patents over the next year, a strong opportunity opens up for manufacturers to launch their own generic versions in the US.
Carlo Novi Managing Director Sales, HealthCare Solutions , FedEx Express EMEA
10 Sep 12
The issue of gender balance within UK boards has moved quickly up the business agenda following last year’s Davies Report. Lord Davies’ Women on Boards report outlined the benefits that a mixed board brings in terms of skills and different perspectives and recommended that a minimum of 25% of FTSE 100 board members should be female by 2015.
PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.